NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,279.08 mln
Float41.22 mln
Earnings Date08/05/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
43.38
Transformational upside
Relative Strength
25
/ 100
Underperforming
Debt / Equity
0.00
Debt-free
ROE
-150
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2011 and based in Waltham, Massachusetts, Damora Therapeutics Inc. is a drug development company working on new treatments for blood disorders across Denmark and North America. Its main focus is a group of antibody-based medicines designed to target a specific genetic mutation linked to certain blood cancers, with the goal of helping a broad range of patients affected by this condition. The company is also advancing a small molecule drug aimed at treating acute myeloid leukemia.
